Tonix Pharmaceuticals (TNXP) Short Interest Ratio & Short Volume → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free TNXP Stock Alerts $0.18 +0.01 (+5.76%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Tonix Pharmaceuticals Short Interest DataCurrent Short Volume1,490,000 sharesPrevious Short Volume1,250,000 sharesChange Vs. Previous Month+19.20%Dollar Volume Sold Short$217,391.00Short Interest Ratio / Days to Cover0.7Last Record DateApril 15, 2024Outstanding Shares84,490,000 sharesFloat Size84,490,000 sharesShort Percent of Float1.76%Today's Trading Volume2,283,382 sharesAverage Trading Volume2,520,595 sharesToday's Volume Vs. Average91% Short Selling Tonix Pharmaceuticals ? Sign up to receive the latest short interest report for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTNXP Short Interest Over TimeTNXP Days to Cover Over TimeTNXP Percentage of Float Shorted Over Time Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Tonix Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,490,000 shares $217,391.00 +19.2%1.8%0.7 $0.15 3/31/20241,250,000 shares $232,500.00 +29.3%1.5%0.6 $0.19 3/15/2024967,000 shares $310,407.00 +56.9%1.2%0.6 $0.32 2/29/2024616,200 shares $233,046.84 +3.3%0.8%0.3 $0.38 2/15/2024596,500 shares $230,249.00 -6.5%0.7%0.3 $0.39 1/31/2024638,200 shares $204,224.00 +132.1%0.8%0.4 $0.32 Get the Latest News and Ratings for TNXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024275,000 shares $81,455.00 -20.4%0.3%0.2 $0.30 12/31/2023345,300 shares $139,155.90 -77.0%0.6%0.3 $0.40 12/15/20231,500,000 shares $857,700.00 +308.7%5.6%1.4 $0.57 11/30/2023367,000 shares $190,106.00 +270.0%1.5%0.7 $0.52 11/15/202399,200 shares $46,723.20 -70.1%0.4%0.3 $0.47 10/31/2023331,600 shares $195,644.00 +21.2%1.2%1.1 $0.59 10/15/2023273,600 shares $159,727.68 -31.4%1.0%0.6 $0.58 9/30/2023398,700 shares $217,291.50 +277.9%2.3%0.9 $0.55 9/15/2023105,500 shares $97,060.00 -65.5%0.6%0.3 $0.92 8/31/2023305,600 shares $295,331.84 -33.3%1.7%0.7 $0.97 8/15/2023458,200 shares $439,093.06 -71.5%2.6%1 $0.96 7/31/20231,610,000 shares $1.72 million +12.6%15.0%3.4 $1.07 7/15/20231,430,000 shares $2.52 million -4.7%13.9%5.3 $1.76 6/30/20231,500,000 shares $2.37 million +32.7%14.5%5.5 $1.58 6/15/20231,130,000 shares $2.17 million +13.4%11.0%4.5 $1.92 5/31/2023996,900 shares $1.78 million +56.1%9.7%4.5 $1.79 5/15/2023638,800 shares $1.23 million +167.6%6.2%2.9 $1.92 4/30/20231,490,000 shares $774,800.00 +2.8%2.4%1.3 $0.52 4/15/20231,450,000 shares $745,445.00 -42.0%2.3%1 $0.51 3/31/20232,500,000 shares $1.48 million -18.6%4.0%0.9 $0.59 3/15/20233,070,000 shares $1.73 million +15.9%4.9%0.8 $0.56 2/28/20232,650,000 shares $1.86 million -27.0%4.4%0.4 $0.70 2/15/20233,630,000 shares $3.88 million -14.6%6.0%0.5 $1.07 1/31/20234,250,000 shares $4.76 million -24.9%7.4%0.6 $1.12 1/15/20235,660,000 shares $7.36 million +68.5%9.8%0.9 $1.30 12/30/20223,360,000 shares $1.31 million -21.5%5.8%0.6 $0.39 12/15/20224,280,000 shares $1.39 million +210.1%7.4%1 $0.33 11/30/20221,380,000 shares $531,300.00 +123.2%2.4%0.8 $0.39 11/15/2022618,200 shares $306,009.00 -34.6%1.1%0.3 $0.50 10/31/2022945,400 shares $426,375.40 -16.3%1.7%0.4 $0.45 10/15/20221,130,000 shares $541,835.00 +1.8%2.5%0.2 $0.48 9/30/20221,110,000 shares $592,962.00 -41.6%2.5%0.2 $0.53 9/15/20221,900,000 shares $1.64 million -20.8%4.2%0.3 $0.86 8/31/20222,400,000 shares $2.45 million -4.0%5.4%0.3 $1.02Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. TNXP Short Interest - Frequently Asked Questions What is Tonix Pharmaceuticals' current short interest? Short interest is the volume of Tonix Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,490,000 shares of TNXP short. 1.76% of Tonix Pharmaceuticals' shares are currently sold short. Learn More on Tonix Pharmaceuticals' current short interest. What is a good short interest ratio for Tonix Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNXP shares currently have a short interest ratio of 1.0. Learn More on Tonix Pharmaceuticals's short interest ratio. What is a good short interest percentage for Tonix Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.76% of Tonix Pharmaceuticals' floating shares are currently sold short. Is Tonix Pharmaceuticals' short interest increasing or decreasing? Tonix Pharmaceuticals saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,490,000 shares, an increase of 19.2% from the previous total of 1,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tonix Pharmaceuticals' float size? Tonix Pharmaceuticals currently has issued a total of 84,490,000 shares. Some of Tonix Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tonix Pharmaceuticals currently has a public float of 84,490,000 shares. How does Tonix Pharmaceuticals' short interest compare to its competitors? 1.76% of Tonix Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tonix Pharmaceuticals: Vaxxinity, Inc. (9.31%), Aytu BioPharma, Inc. (7.51%), Pieris Pharmaceuticals, Inc. (0.03%), Edesa Biotech, Inc. (0.65%), FSD Pharma Inc. (1.11%), Cocrystal Pharma, Inc. (0.02%), NeuroBo Pharmaceuticals, Inc. (2.63%), VBI Vaccines Inc. (2.65%), Minerva Neurosciences, Inc. (0.56%), Kiora Pharmaceuticals, Inc. (0.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Tonix Pharmaceuticals stock? Short selling TNXP is an investing strategy that aims to generate trading profit from Tonix Pharmaceuticals as its price is falling. TNXP shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tonix Pharmaceuticals? A short squeeze for Tonix Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNXP, which in turn drives the price of the stock up even further. How often is Tonix Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNXP, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VAXX Short Interest Data AYTU Short Interest Data PIRS Short Interest Data EDSA Short Interest Data HUGE Short Interest Data COCP Short Interest Data NRBO Short Interest Data VBIV Short Interest Data NERV Short Interest Data KPRX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNXP) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldBiden Nomination CANCELED?The Freeport SocietyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith